Home-Based Virtual Reality Exergame Program after Stroke Rehabilitation for Patients with Stroke: A Study Protocol for a Multicenter, Randomized Controlled Trial.
Dongheon KangJiyoung ParkSeon-Deok EunPublished in: Life (Basel, Switzerland) (2023)
It is essential for stroke patients to maintain their therapy even after discharging inpatient rehabilitation. This is because recovery is an ongoing process that requires consistent effort. Virtual reality exergame training (VRET) is becoming widely used in stroke rehabilitation to improve physical, social, and psychological outcomes. Home-based VRET may be a more convenient and accessible option for stroke rehabilitation. This study will aim to determine the effectiveness of home-based VRET for patients with stroke who have been discharged from the hospital. This trial will randomly assign 120 participants to 8 weeks of either a VRET (intervention group) or daily life (control group). The study will measure cardiopulmonary endurance, muscular strength, functional capacity, gait, activities of daily living, and quality of life. Our main objective is to determine whether it is safe for patients to undergo VRET at home after they have been discharged from the hospital with a doctor's note. Additionally, we aim to examine whether stroke patients are capable of exercising at home after being discharged from the hospital. This study's outcome could pave the way for developing more comprehensive exercise protocols for stroke patients. Our findings will provide valuable insights into the efficacy of VRET as a therapeutic tool for stroke patients.
Keyphrases
- virtual reality
- randomized controlled trial
- atrial fibrillation
- healthcare
- mental health
- end stage renal disease
- systematic review
- clinical trial
- type diabetes
- chronic kidney disease
- newly diagnosed
- acute care
- stem cells
- quality improvement
- adipose tissue
- metabolic syndrome
- cross sectional
- prognostic factors
- depressive symptoms
- cerebral palsy
- smoking cessation
- double blind
- phase ii
- patient reported